<p><strong>Hepatic Impairment</strong>:&nbsp;Ulipristal acetate is not recommended in patients with severe hepatic impairment unless the patient is closely monitored.<br />
<br />
<strong>Renal Impairment</strong>:&nbsp;Renal impairment is not expected to significantly alter the elimination of ulipristal acetate. In the absence of specific studies, ulipristal acetate is not recommended for patients with moderate and severe renal impairment unless the patient is closely monitored.</p>